InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P50
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-6.34%
20243.42%
202357.27%
2022-47.04%
2021-41.50%
202010.70%
2019-49.22%
2018-95.01%
2017-87.22%
201646.87%